Back to search
Hyperphosphatemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperphosphatemia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperphosphatemia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receiving maintena…
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysis
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on hemodialysis
A phase 3, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…
The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions…
This study will be conducted to assess the safety and tolerability of ferric citrate in pediatric participants with hyperphosphatemia related to chronic kidney…
The primary objective of this study is to demonstrate the long-term safety and tolerability of MCI-196 in the subjects with stage V chronic kidney disease on di…